-+ 0.00%
-+ 0.00%
-+ 0.00%

*AbbVie 3Q Global Net Revenue From Immunology Portfolio $9.165B, Up 16.5% >ABBV

Dow Jones·10/30/2026 11:46:00

Please log in to view news